- Home
- INKT vs HOOK Comparison
INKT vs HOOK Comparison
Compare INKT & HOOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INKT
- HOOK
- Stock Information
- Founded
- INKT 2017
- HOOK 2011
- Country
- INKT United States
- HOOK United States
- Employees
- INKT N/A
- HOOK N/A
- Industry
- INKT Medicinal Chemicals and Botanical Products
- HOOK Biotechnology: Pharmaceutical Preparations
- Sector
- INKT Health Care
- HOOK Health Care
- Exchange
- INKT Nasdaq
- HOOK Nasdaq
- Market Cap
- INKT 28.5M
- HOOK 30.2M
- IPO Year
- INKT 2021
- HOOK 2019
- Fundamental
- Price
- INKT $0.46
- HOOK $2.00
- Analyst Decision
- INKT Strong Buy
- HOOK Strong Buy
- Analyst Count
- INKT 2
- HOOK 4
- Target Price
- INKT $6.50
- HOOK $34.50
- AVG Volume (30 Days)
- INKT 43.7K
- HOOK 66.7K
- Earning Date
- INKT 11-14-2024
- HOOK 11-14-2024
- Dividend Yield
- INKT N/A
- HOOK N/A
- EPS Growth
- INKT N/A
- HOOK N/A
- EPS
- INKT N/A
- HOOK N/A
- Revenue
- INKT N/A
- HOOK $49,999,000.00
- Revenue This Year
- INKT N/A
- HOOK $147.52
- Revenue Next Year
- INKT N/A
- HOOK N/A
- P/E Ratio
- INKT N/A
- HOOK N/A
- Revenue Growth
- INKT N/A
- HOOK 143.30
- 52 Week Low
- INKT $0.46
- HOOK $1.88
- 52 Week High
- INKT $1.90
- HOOK $11.30
- Technical
- Relative Strength Index (RSI)
- INKT 15.27
- HOOK 26.63
- Support Level
- INKT $0.64
- HOOK $2.01
- Resistance Level
- INKT $0.67
- HOOK $2.27
- Average True Range (ATR)
- INKT 0.06
- HOOK 0.18
- MACD
- INKT -0.02
- HOOK 0.02
- Stochastic Oscillator
- INKT 0.00
- HOOK 31.94
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.